201 related articles for article (PubMed ID: 22110898)
1. Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment.
Rego EM; De Santis GC
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011048. PubMed ID: 22110898
[TBL] [Abstract][Full Text] [Related]
2. [Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report].
Di Micco L; Mirenghi F; Morelli E; De Simone E
G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373469
[TBL] [Abstract][Full Text] [Related]
3. The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature.
Montesinos P; Sanz MA
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011059. PubMed ID: 22220256
[TBL] [Abstract][Full Text] [Related]
4. Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome.
Luesink M; Pennings JL; Wissink WM; Linssen PC; Muus P; Pfundt R; de Witte TJ; van der Reijden BA; Jansen JH
Blood; 2009 Dec; 114(27):5512-21. PubMed ID: 19828696
[TBL] [Abstract][Full Text] [Related]
5. Differentiation syndrome in acute promyelocytic leukaemia.
Stahl M; Tallman MS
Br J Haematol; 2019 Oct; 187(2):157-162. PubMed ID: 31410848
[TBL] [Abstract][Full Text] [Related]
6. Acute Respiratory Distress Syndrome in a Patient With Acute Promyelocytic Leukemia: Overlapping Between Differentiation Syndrome and COVID-19.
Sui J; Kelmenson D; Hu S; Cao L
J Hematol; 2021 Oct; 10(5):217-220. PubMed ID: 34804311
[TBL] [Abstract][Full Text] [Related]
7. Role of Prophylactic Steroids in Differentiation Syndrome.
Sultana J; Dutta J; Mustarin S; Dey P; Roy A; Mamoon MY
Cureus; 2022 Sep; 14(9):e29531. PubMed ID: 36312659
[TBL] [Abstract][Full Text] [Related]
8. Differentiation Syndrome in Acute Leukemia: APL and Beyond.
Woods AC; Norsworthy KJ
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835461
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome.
Cardinale L; Asteggiano F; Moretti F; Torre F; Ulisciani S; Fava C; Rege-Cambrin G
World J Radiol; 2014 Aug; 6(8):583-8. PubMed ID: 25170395
[TBL] [Abstract][Full Text] [Related]
10. Differentiation Syndrome with Severe Abdominal Pain During Induction Treatment of Acute Promyelocytic Leukemia: A Case Report.
Yan H; He D; Huang W; Chen F; He J; Cai Z; Zhao Y
J Pain Res; 2021; 14():1981-1984. PubMed ID: 34234544
[TBL] [Abstract][Full Text] [Related]
11. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
12. Fatal Differentiation Syndrome Complicating Acute Promyelocytic Leukemia Treatment: A Case Report.
Khizer U; Annam B; Akhtar A; Dhaliwal JS; Yang C
Cureus; 2024 Feb; 16(2):e54491. PubMed ID: 38516455
[TBL] [Abstract][Full Text] [Related]
13. A Race Against Time: Early-Onset Differentiation Syndrome Following All-Trans-Retinoic-Acid (ATRA) Therapy in Acute Promyelocytic Leukemia (AML-M3).
Ahmad K; Saleh M; Ali Y; Yaseen A; Ali M; Kakakhel M; Hayat MA
Cureus; 2023 Dec; 15(12):e50042. PubMed ID: 38186512
[TBL] [Abstract][Full Text] [Related]
14. Differentiation Syndrome, a Side Effect From the Therapy of Acute Promyelocytic Leukemia.
Reyhanoglu G; Hughes B; King KE; Cambridge R
Cureus; 2020 Dec; 12(12):e12042. PubMed ID: 33447473
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary corroboration in differentiation syndrome: a case report.
Sarkar S; Ghosh P; Gehani A; Ghara N; Bhattacharyya P
J Med Case Rep; 2021 May; 15(1):226. PubMed ID: 33947461
[TBL] [Abstract][Full Text] [Related]
16. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
[TBL] [Abstract][Full Text] [Related]
17. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
[TBL] [Abstract][Full Text] [Related]
18. The "retinoic acid syndrome" in acute promyelocytic leukemia.
Frankel SR; Eardley A; Lauwers G; Weiss M; Warrell RP
Ann Intern Med; 1992 Aug; 117(4):292-6. PubMed ID: 1637024
[TBL] [Abstract][Full Text] [Related]
19. The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia.
Dore AI; Santana-Lemos BA; Coser VM; Santos FL; Dalmazzo LF; Lima AS; Jacomo RH; Elias J; Falcão RP; Pereira WV; Rego EM
J Leukoc Biol; 2007 Nov; 82(5):1340-3. PubMed ID: 17704297
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells.
Tang L; Chai W; Ye F; Yu Y; Cao L; Yang M; Xie M; Yang L
Oncotarget; 2017 Apr; 8(16):27314-27327. PubMed ID: 28404891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
